Browse MARK JEWELL

1-50 out of 50 article(s)

Title	Date	Words
Fidelity: $85k needed for long-term care costs	Jun 26, 2008	698
Plastics expert wins $500K Lemelson-MIT award	Jun 25, 2008	313
Icahn loses campaign to change Biogen Idec board	Jun 19, 2008	670
Boston Scientific sells investments to raise $140M	Jun 19, 2008	410
Another potential $1B deal for RNAi drug technology	May 27, 2008	502
Express Scripts to pay $9.5M in settlement	May 27, 2008	457
Biogen Idec 1Q profit up 24 percent, helped by MS drug	Apr 23, 2008	543
Expense cuts boost Boston Scientific profit to $322 million	Apr 22, 2008	559
Thermo Fisher CEO sees 2007 pay package drop, but realizes $65 million from options	Apr 10, 2008	433
Boston Scientific CEO James Tobin receives $2 million in tough 2007, one-tenth of 2006 award	Mar 19, 2008	446
Roche agrees to judge's conditions for selling anemia drug Mircera	Mar 18, 2008	595
US judge increases damages against Boston Scientific in stent patent case; award totals $501M	Feb 15, 2008	324
Jury orders Boston Scientific to pay $432 million in stent patent dispute	Feb 12, 2008	628
Biogen Idec 4Q profit up 84 pct; firm wary of extended search for buyer	Feb 6, 2008	453
Acquisition costs continue to pummel Boston Scientific	Feb 5, 2008	522
Activist investor submits 3 board nominees to Biogen Idec, slams company	Jan 28, 2008	591
Biogen Idec shares plunge 28 percent after it says it's ending search for potential buyer	Dec 13, 2007	437
Biogen Idec 3Q profit, revenue fall, miss Wall Street expectations	Oct 23, 2007	402
Biogen Idec 3Q profit, revenue fall, miss Wall Street expectations	Oct 23, 2007	510
Amid possible buyout, Biogen Idec misses Street's 3Q expectations	Oct 23, 2007	542
Amid possible buyout, Biogen Idec misses Street's 3Q expectations	Oct 23, 2007	541
Boston Scientific posts $272 million third-quarter loss, beats Wall Street expectations	Oct 19, 2007	202
Boston Scientific posts $272 million third-quarter loss	Oct 19, 2007	421
Boston Scientific posts $272 million third-quarter loss	Oct 19, 2007	446
Boston Scientific posts $272 million third-quarter loss	Oct 19, 2007	596
Shares gain despite $272 million loss for Boston Scientific	Oct 19, 2007	562
Shares gain despite $272 million loss for Boston Scientific	Oct 19, 2007	562
Boston Scientific cuts 2,300 jobs amid broader retrenchment	Oct 18, 2007	347
Boston Scientific says to cut 2,300 jobs, restructure units	Oct 17, 2007	233
Pfizer becomes latest to partner with fast-growing online doctors' forum Sermo	Oct 15, 2007	654
Biogen Idec exploring potential sale of company	Oct 12, 2007	438
Boston Scientific puts more Guidant liability behind it with $17M settlement	Aug 30, 2007	596
Boston Scientific amends terms of 2004 acquisition that soured	Aug 9, 2007	422
Boston Scientific opts not to spin off stake in endosurgery group	Aug 2, 2007	498
Biogen Idec swings to 2nd-quarter profit on higher sales, minus year-ago buyout charges	Jul 24, 2007	509
Ariad cancer drug partnership with Merck may be worth $1 billion	Jul 12, 2007	509
Gene-silencing therapy at heart of potential $1 billion licensing pact	Jul 9, 2007	637
AMA, Wall Street tap into doctors' collective insight via new Web service	May 30, 2007	879
Boston Scientific profit drops on Guidant costs, sagging stent sales	Apr 24, 2007	569
Boston Scientific profit plunges on Guidant costs, sagging stent sales	Apr 23, 2007	566
Heart stent makers brace for results of new study comparing artery-opening to drugs alone	Mar 24, 2007	967
Heart stent makers brace for results of new study comparing artery-opening to drugs alone	Mar 23, 2007	976
Zipcar expands from NY, other states	Mar 13, 2007	674
Boston Scientific CEO awarded compensation valued at $23 million in 2006, despite tough year	Mar 8, 2007	649
Legal liability mounts for Boston Scientific after Guidant deal	Mar 2, 2007	685
Biogen Idec doubles its 4th-quarter profit on sales of Rituxan and Avonex	Feb 15, 2007	577
Biogen Idec doubles its 4th-quarter profit, but misses Street estimate	Feb 15, 2007	608
Boston Scientific profit drops on sagging stent sales	Feb 1, 2007	594
More Defibrillators, Pacemakers Recalled	Jun 26, 2006	457
Guidant Letter About Risks Never Sent	Jun 9, 2006	868